Three-dimensional (3D) MRI is similar to 2D for diagnosing meniscus knee injuries, but may be able to cut down on image acquisition time, reported authors of a Nov. 20 study published in Radiology.

New research presented at RSNA 2018 in Chicago suggested women 75 years and older should continue to get annual screening mammograms due to the high incidence of breast cancer found in this population.

Images from the world’s first whole-body MRI scanner are set to be presented at this year’s 2018 RSNA Annual Meeting in Chicago, according to a University of California, Davis statement.

A model based on radiomic features extracted from CT scans can help predict which ground glass nodule (GGN) cases require surgery and may reduce overtreatment, according to researchers at the Affiliated Suzhou Hospital of Nanjing Medical University in Suzhou, China.

Powered by Philips HealthSuite, open platform offers radiologists comprehensive data analytics in medical imaging

A machine learning algorithm based on perfusion-weighted MRI accurately differentiated between benign and malignant tumors in the uterus, according to researchers at Tehran University of Medical Sciences (TUMS) in Iran.

The American Cancer Society (ACS) released a new report highlighting the current state of cancer screening and put forth specific areas requiring further attention to fully maximize the potential of screening to combat cancer.

Brightness of the shoulder’s deltoid muscle on ultrasound can identify patients with type 2 diabetes or pre-diabetes with almost 90 percent accuracy, according to a study being presented at the Radiological Society of North America (RSNA)’s 2018 Annual Meeting next week in Chicago.

“The new 2018 Digital Mammography QC Manual will promote uniformity and consistency of QC procedures across the broad spectrum of FDA approved manufacturers,” Eric Berns, PhD, manual author and chair of the ACR Subcommittee on Mammography Quality Assurance, said in a prepared statement.

A New York City-based medtech startup called Ezra is about to replace pain inducing blood tests and biopsies with MRIs as part of its new prostate cancer screening subscription service, according to a recent report by TechCrunch.